These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 23633209)

  • 61. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
    Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
    Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
    Arnold A
    Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
    Evans CO; Brown MR; Parks JS; Oyesiku NM
    J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.
    Mannstadt M; Holick E; Zhao W; Jüppner H
    J Endocrinol; 2011 Aug; 210(2):165-71. PubMed ID: 21642377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
    Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
    Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. No evidence of RET germline mutations in familial pituitary adenoma.
    Heliövaara E; Tuupanen S; Ahlsten M; Hodgson S; de Menis E; Kuismin O; Izatt L; McKinlay Gardner RJ; Gundogdu S; Lucassen A; Arola J; Tuomisto A; Mäkinen M; Karhu A; Aaltonen LA
    J Mol Endocrinol; 2011 Feb; 46(1):1-8. PubMed ID: 20956458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
    Yarman S; Tuncer FN; Serbest E
    Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
    Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
    J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
    [TBL] [Abstract][Full Text] [Related]  

  • 73. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.
    Cetani F; Pinchera A; Pardi E; Cianferotti L; Vignali E; Picone A; Miccoli P; Viacava P; Marcocci C
    J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.
    Shattuck TM; Costa J; Bernstein M; Jensen RT; Chung DC; Arnold A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
    Yarman S; Ogret YD; Oguz FS
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
    Costa-Guda J; Arnold A
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
    Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
    Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.